墨西哥多发性骨髓瘤:对公共保险队列中长期生存的回顾性研究
Juan Carlos Solis-Poblano1, María Teresa Itzmoyotl-Hernández2, Uendy Pérez-Lozano1
1Departamento de Hematología, Unidad Médica de Alta Especialidad Manuel Ávila Camacho, Instituto Mexicano del Seguro Social, Puebla, México.
Leukemia & lymphoma
|December 16, 2025
概括
这项研究发现,较高的血红蛋白水平可以保护多发性骨髓瘤患者,而高的乳酸脱酶水平则表明死亡风险更高. 这些因素可以指导治疗决策,特别是当先进的测试无法使用时.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床研究 临床研究
背景情况:
- 多发性骨髓瘤治疗结果显著不同.
- 确定预后因素对于患者管理和资源分配至关重要.
- 自主干细胞移植 (ASCT) 是一种关键的治疗方式,但其可访问性和影响需要持续评估.
研究的目的:
- 评估多发性骨髓瘤患者的整体生存 (OS) 和无进展生存 (PFS) 的预后因素.
- 评估自身干细胞移植 (ASCT) 对生存结果的影响.
- 通过使用现有的临床标志物探索实用性预后方法.
主要方法:
- 在2002年至2024年期间治疗的293名成年多发性骨髓瘤患者的回顾性分析.
- 卡普兰-梅尔分析用于生存估计.
- 考克斯的比例风险模型用于预后因素的多变量分析.
主要成果:
- 随访时间的中位数为2.9年,10年后的生存率为60%.
- 较高的血红蛋白水平与改善的生存率显著相关 (HR 0.79,p=0.003).
- 乳酸脱酶 (LDH) 的升高与增加的死亡率有关 (HR 1.63,p=0.010). ASCT显示了未经调整的OS有所改善的趋势,但在调整后并不显著.
结论:
- 乳酸脱酶 (LDH) 和血红蛋白是多发性骨髓瘤的宝贵预后标志物.
- 这些标记可以为风险分层提供信息,并指导及时转诊进行自身干细胞移植 (ASCT),特别是在资源有限的环境中.
- 在没有先进的测试可用的情况下,可能可以采用包含血红蛋白的务实,没有FISH细胞遗传学的预后模型.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.4K
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
7.2K
相关概念视频
01:21Cancer Survival Analysis
629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629
01:24Kaplan-Meier Approach
536
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
536
01:20Comparing the Survival Analysis of Two or More Groups
533
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
533
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:20Actuarial Approach
276
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
276
02:20Longitudinal Research
13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K